Backed Evanium's €2.2M seed round for ingredient technology.
Evanium develops novel, IP-protected health ingredients based on secondary plant compounds for the food, cosmetic, and pharmaceutical industries, utilizing their OPTISOLV® Technology to enhance the solubility and bioavailability of natural ingredients
Evanium develops novel, IP-protected health ingredients based on secondary plant compounds for the food, cosmetic, and pharmaceutical industries, utilizing their OPTISOLV® Technology to enhance the solubility and bioavailability of natural ingredients.